Addus HomeCare (ADUS) director Esteban Lopez sells 250 common shares at $93

Rhea-AI Filing Summary

Addus HomeCare Corp director Esteban Lopez sold shares in an open-market transaction. On May 21, 2026, he sold 250 shares of Addus HomeCare common stock at a price of $93.00 per share. Following this sale, he directly owns 3,200 shares of the company’s common stock.

Insider Trade Summary

Net Seller: 250 shares ($23,250)

Net Sell 1 txn

Insider Lopez Esteban

Role null

Sold 250 shs ($23K)

Type	Security	Shares	Price	Value
Sale	Common Stock	250	$93.00	$23K

Holdings After Transaction: Common Stock — 3,200 shares (Direct, null)

Footnotes (1)

Key Figures

Shares sold: 250 shares Sale price: $93.00 per share Shares owned after transaction: 3,200 shares +1 more

4 metrics

Shares sold 250 shares Open-market sale of common stock on May 21, 2026

Sale price $93.00 per share Price for the 250 shares sold

Shares owned after transaction 3,200 shares Total direct holdings following the sale

Net share change 250 shares net sold transactionSummary netBuySellShares

Key Terms

open-market sale, Common Stock, Form 4

3 terms

open-market sale financial

"transaction_action: open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

"security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lopez Esteban

(Last) (First) (Middle)

6303 COWBOYS WAY

SUITE 600

(Street)

FRISCO TEXAS 75034

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Addus HomeCare Corp [ ADUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/21/2026		S		250	D	$93	3,200	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Brian Poff, Attorney-In-Fact for Esteban Lopez	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Addus HomeCare Corp (ADUS) disclose for Esteban Lopez?

Addus HomeCare disclosed that director Esteban Lopez executed an open-market sale of company stock. He sold 250 shares of Addus HomeCare common stock at $93.00 per share, leaving him with direct ownership of 3,200 shares after the transaction.

How many Addus HomeCare (ADUS) shares did Esteban Lopez sell and at what price?

Esteban Lopez sold 250 shares of Addus HomeCare common stock in a single transaction. The reported sale price was $93.00 per share, as disclosed in the Form 4 insider trading report filed for this transaction.

What is Esteban Lopez’s remaining Addus HomeCare (ADUS) shareholding after the reported sale?

After selling 250 shares, Esteban Lopez directly owns 3,200 shares of Addus HomeCare common stock. This post-transaction holding figure is explicitly reported in the Form 4 as the total number of shares following the sale.

Was the Addus HomeCare (ADUS) insider transaction by Esteban Lopez an open-market sale?

Yes, the transaction is classified as an open-market sale of common stock. The Form 4 describes the code as a sale in an open market or private transaction, and labels the transaction action specifically as an open-market sale.

Did the Addus HomeCare (ADUS) Form 4 include any derivative securities for Esteban Lopez?

No derivative securities are reported for this transaction. The filing shows one non-derivative transaction involving common stock and indicates an empty derivative summary, meaning no options or other derivatives were part of this Form 4.